Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.

Eccleston A, Bentley A, Dyer M, Strydom A, Vereecken W, George A, Rahman N.

Value Health. 2017 Apr;20(4):567-576. doi: 10.1016/j.jval.2017.01.004. Epub 2017 Mar 3.

2.

Cost-Effectiveness Analysis of Testing for Brca1 and Brca2 Mutations In Women Diagnosed With Ovarian Cancer and Their Female First- And Second Degree Relatives Using A Discrete Event Simulation: A Uk Health Service Perspective.

Eccleston A, Bentley A, Dyer M, Vereecken W, George A, Rahman N.

Value Health. 2015 Nov;18(7):A361. doi: 10.1016/j.jval.2015.09.697. Epub 2015 Oct 20. No abstract available.

3.

Cost-Effectiveness Analysis of Testing for Brca Mutations in Women Diagnosed with Ovarian Cancer and their Female First-Degree Relatives: A Uk Health Service Perspective.

Dyer M, Vereecken W, Worrall J, George A, Rahman N.

Value Health. 2014 Nov;17(7):A643-4. doi: 10.1016/j.jval.2014.08.2327. Epub 2014 Oct 26. No abstract available.

4.

Worldwide electricity consumption of communication networks.

Lambert S, Van Heddeghem W, Vereecken W, Lannoo B, Colle D, Pickavet M.

Opt Express. 2012 Dec 10;20(26):B513-24. doi: 10.1364/OE.20.00B513.

PMID:
23262896

Supplemental Content

Loading ...
Support Center